Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have been given a consensus recommendation of “Reduce” by the sixteen brokerages that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $10.5667.
A number of research analysts have issued reports on AVTR shares. Wall Street Zen lowered shares of Avantor from a “buy” rating to a “hold” rating in a report on Saturday, May 30th. Robert W. Baird set a $11.00 target price on shares of Avantor in a report on Thursday, February 12th. Morgan Stanley set a $10.00 target price on shares of Avantor in a report on Friday, February 13th. Wolfe Research lowered shares of Avantor to an “underperform” rating and set a $7.00 target price on the stock. in a report on Monday, June 1st. Finally, Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th.
Avantor Price Performance
Avantor (NYSE:AVTR – Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The firm’s quarterly revenue was up .0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.23 EPS. On average, equities research analysts predict that Avantor will post 0.79 EPS for the current fiscal year.
Insider Transactions at Avantor
In related news, Director Simon Dingemans acquired 25,000 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was bought at an average price of $8.14 per share, with a total value of $203,500.00. Following the purchase, the director directly owned 25,000 shares in the company, valued at $203,500. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gregory T. Lucier acquired 10,000 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were bought at an average cost of $8.32 per share, with a total value of $83,200.00. Following the purchase, the director owned 60,000 shares in the company, valued at approximately $499,200. The trade was a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 0.28% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Parallel Advisors LLC increased its stake in shares of Avantor by 21.4% during the 1st quarter. Parallel Advisors LLC now owns 8,452 shares of the company’s stock valued at $66,000 after acquiring an additional 1,491 shares during the last quarter. Verus Capital Partners LLC acquired a new stake in Avantor during the 1st quarter worth approximately $111,000. Bank of America Corp DE increased its position in Avantor by 24.3% during the 1st quarter. Bank of America Corp DE now owns 7,067,563 shares of the company’s stock worth $55,410,000 after purchasing an additional 1,382,320 shares in the last quarter. Edgestream Partners L.P. increased its position in Avantor by 21.8% during the 1st quarter. Edgestream Partners L.P. now owns 418,095 shares of the company’s stock worth $3,278,000 after purchasing an additional 74,728 shares in the last quarter. Finally, ADAR1 Capital Management LLC increased its position in Avantor by 14.3% during the 1st quarter. ADAR1 Capital Management LLC now owns 80,000 shares of the company’s stock worth $627,000 after purchasing an additional 10,000 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
See Also
- Five stocks we like better than Avantor
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
